Norges Bank
CALA

Norges Bank’s Calithera Biosciences, Inc CALA Stock Holding History

Norges Bank’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,500
Closed -$737K – 2219
2020
Q4 		$737K Sell
7,500
-14,905
-67% -$1.31M ﹤0.01% 2055
2020
Q3 		$1.55M Buy
22,405
+14,905
+199% +$1.3M ﹤0.01% 1989
2020
Q2 		$792K Buy
+7,500
New +$891K ﹤0.01% 2028

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank's CALA Position: Q1 2021 in Review

Norges Bank sold out of Calithera Biosciences, Inc (CALA) in Q1 2021, closing a stake of 7,500 shares — an estimated $737K sold.

Norges Bank first reported a position in CALA in Q2 2020 and held it in 3 quarters. The position peaked at $1.55M in Q3 2020. 100 funds tracked by Wall St. Rank hold CALA as of Q1 2021.

  • Norges Bank reported no remaining Calithera Biosciences, Inc position as of Q1 2021 after selling out during the quarter.
  • Norges Bank sold 7,500 Calithera Biosciences, Inc shares in Q1 2021, an estimated $737K.
  • Norges Bank first reported a position in Calithera Biosciences, Inc in Q2 2020 and held it in 3 quarters.
  • Norges Bank's Calithera Biosciences, Inc position peaked at $1.55M in Q3 2020.
  • 100 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2021.

Based on Norges Bank's 13F filing for Q1 2021, filed 7 May 2021.